Characteristic | Control group | Intervention group |
---|---|---|
n = 3,293 | n = 2,185 | |
Age, mean (SD) | 84.6 (10.7) (n = 3,274) | 84.0 (11.1) (n = 2,178) |
Female, % (n) | 71.1 (2,329/3,277) | 70.4 (1,532/2,175) |
Number of medications, mean (SD) | 9.2 (4.3) (n = 3,293) | 9.7 (4.7) (n = 2,185) |
Vitamin D (≥800 IU/day), % (n) | 41.8 (1,378/3,293) | 36.0 (787/2,185) |
Calcium (≥500 mg/day), % (n) | 34.8 (1,145/3,293) | 30.7 (671/2,185) |
Osteoporosis medication, % (n) | 22.7 (747/3,293) | 17.0 (372/2,185) |
 High-risk residents,* % (n) | 34.8 (412/1,185) | 26.7 (181/678) |
Hip fracture (prevalent), % (n) | 7.0 (230/3,290) | 5.0 (109/2,183) |
Vertebral fracture (prevalent), % (n) | 1.4 (46/3,290) | 0.9 (20/2,183) |
Osteoporosis diagnosis, % (n) | 31.3 (1030/3,290) | 27.8 (607/2,183) |
High-risk, % (n)* | 36.0 (1185/3,293) | 31.0 (678/2,185) |